| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |